The advertisement promotes Xtandi (enzalutamide) for the treatment of nonmetastatic castration-sensitive prostate cancer and provides important safety information regarding the risk of seizures.
Creative Information
| CID: | b9518556-4bea-4905-b175-935896b24102 |
| CRID: | 82_7182-947428 |
| Domain: | xtandihcp.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $78.38 |
| Timestamp: | 11/1/2025, 5:03:11 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/1/2025, 6:01:33 AM | 5.70s | |
| adomain_analysis | success | 11/1/2025, 6:25:00 AM | 2.60s | |
| adomain_capture | success | 11/1/2025, 6:24:57 AM | 0.07s | |
| ad_render | success | 11/1/2025, 6:01:27 AM | 24.54s | |
| brand_mapping | success | 11/1/2025, 5:03:11 AM | 0.12s | |
Analysis Results
Ad Format: banner
Brands: XTANDI
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1301.06 KB | ||||||||||||||||||||||
| Render Time: | 9.02 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1301.19 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


